Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review)

  • Li X
  • Lv J
  • Li J
  • et al.
N/ACitations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

As the major cause of irreversible loss of vision in adults, diabetic retinopathy (DR) is one of the most serious complications of diabetes. The imbalance of the retinal micro-environment and destruction of the blood-retinal barrier have a significant role in the progression of DR. Inward rectifying potassium channel 4.1 (Kir4.1) is located on Müller cells and is closely related to potassium homeostasis, water balance and glutamate clearance in the whole retina. The present review discusses the functions of Kir4.1 in regulating the retinal microenvironment and related biological mechanisms in DR. In the future, Kir4.1 may represent a novel alternative therapeutic target for DR through affecting the retinal microenvironment.

Cite

CITATION STYLE

APA

Li, X., Lv, J., Li, J., & Ren, X. (2021). Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review). Experimental and Therapeutic Medicine, 22(3). https://doi.org/10.3892/etm.2021.10453

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free